Clinical Trial

Evaluation of Adherence, Persistence and Efficacy of Treatment With Alirocumab 300mg in Italy

Study acronym: ALINET
Recruiting
View on ClinicalTrials.gov →
Summary
Evaluation of adherence, persistence and efficacy of treatment with alirocumab 300 mg in a real-life Italian population.
Trial Details
NCT Number NCT07375225
Lead Sponsor Federico II University
Conditions Hypercholesterolaemia
Enrollment 1,500 participants
Start Date 2024-12-01
Primary Completion 2026-12-01 (estimated)
Study Completion 2027-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-29